These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2159452)

  • 1. A fast, simple reactivation method for the study of HSV-1 latency in the rabbit ocular model.
    Gordon YJ; Romanowski E; Araullo-Cruz T
    Invest Ophthalmol Vis Sci; 1990 May; 31(5):921-4. PubMed ID: 2159452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corneal nerve disruption reactivates virus in rabbits latently infected with HSV-1.
    Beyer CF; Hill JM; Reidy JJ; Beuerman RW
    Invest Ophthalmol Vis Sci; 1990 May; 31(5):925-32. PubMed ID: 2159453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivation of HSV-1 in primates by transcorneal iontophoresis of adrenergic agents.
    Rootman DS; Haruta Y; Hill JM
    Invest Ophthalmol Vis Sci; 1990 Mar; 31(3):597-600. PubMed ID: 2156785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HSV-1 shedding by lontophoresis of 6-hydroxydopamine followed by topical epinephrine.
    Shimomura Y; Gangarosa LP; Kataoka M; Hill JM
    Invest Ophthalmol Vis Sci; 1983 Dec; 24(12):1588-94. PubMed ID: 6418684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corneal nerves are necessary for adrenergic reactivation of ocular herpes.
    Rootman DS; Haruta Y; Hill JM; Kaufman HE
    Invest Ophthalmol Vis Sci; 1988 Mar; 29(3):351-6. PubMed ID: 2830200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of an improved murine iontophoresis reactivation model for the study of HSV-1 latency.
    Gordon YJ; Araullo-Cruz TP; Romanowski E; Ruziczka L; Balouris C; Oren J; Cheng KP; Kim S
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1230-4. PubMed ID: 3015823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of ocular herpes simplex virus shedding by iontophoresis of epinephrine into rabbit cornea.
    Kwon BS; Gangarosa LP; Burch KD; deBack J; Hill JM
    Invest Ophthalmol Vis Sci; 1981 Sep; 21(3):442-9. PubMed ID: 6268564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivation of murine latent HSV infection by epinephrine iontophoresis.
    Willey DE; Trousdale MD; Nesburn AB
    Invest Ophthalmol Vis Sci; 1984 Aug; 25(8):945-50. PubMed ID: 6086546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes simplex virus recovery in neural tissues after ocular HSV shedding induced by epinephrine iontophoresis to the rabbit cornea.
    Hill JM; Kwon BS; Shimomura Y; Colborn GL; Yaghmai F; Gangarosa LP
    Invest Ophthalmol Vis Sci; 1983 Feb; 24(2):243-7. PubMed ID: 6298139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a murine model of recurrent herpes simplex viral keratitis induced by ultraviolet B radiation.
    Laycock KA; Lee SF; Brady RH; Pepose JS
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2741-6. PubMed ID: 1654309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSV-1 quantitation from rabbit neural tissues after epinephrine-induced reactivation.
    Shimomura Y; Dudley JB; Gangarosa LP; Hill JM
    Invest Ophthalmol Vis Sci; 1985 Jan; 26(1):121-5. PubMed ID: 2981786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient reactivation of latent herpes simplex virus type 1 infection by excimer laser keratectomy in the experimental rabbit ocular model.
    Dhaliwal DK; Barnhorst DA; Romanowski E; Rehkopf PG; Gordon YJ
    Am J Ophthalmol; 1998 Apr; 125(4):488-92. PubMed ID: 9559734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timolol induces HSV-1 ocular shedding in the latently infected rabbit.
    Hill JM; Shimomura Y; Dudley JB; Berman E; Haruta Y; Kwon BS; Maguire LJ
    Invest Ophthalmol Vis Sci; 1987 Mar; 28(3):585-90. PubMed ID: 3030959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of acyclovir on acute and latent herpes simplex virus infections in the rabbit.
    Trousdale MD; Dunkel EC; Nesburn AB
    Invest Ophthalmol Vis Sci; 1980 Nov; 19(11):1336-41. PubMed ID: 7429768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular safety and efficacy of an HSV-1 gD vaccine during primary and latent infection.
    Nesburn AB; Ghiasi H; Wechsler SL
    Invest Ophthalmol Vis Sci; 1990 Aug; 31(8):1497-502. PubMed ID: 2167298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryogenic induced ocular HSV-1 reactivation is enhanced by an inhibitor of the lipoxygenase pathway.
    Beyer CF; Tepper DJ; Hill JM
    Curr Eye Res; 1989 Dec; 8(12):1287-92. PubMed ID: 2560693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous ocular shedding of HSV-1 in latently infected rabbits.
    Berman EJ; Hill JM
    Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):587-90. PubMed ID: 2984140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular lesions associated with dissemination of type 2 herpes simplex virus from skin infection in newborn rabbits.
    Brick DC; Oh JO; Sicher SE
    Invest Ophthalmol Vis Sci; 1981 Nov; 21(5):681-8. PubMed ID: 6271702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of Xalatan on the recovery of ocular herpes simplex virus type 1 (HSV-1) in the induced reactivation and spontaneous shedding rabbit models.
    Gordon YJ; Yates KA; Mah FS; Romanowski EG
    J Ocul Pharmacol Ther; 2003 Jun; 19(3):233-45. PubMed ID: 12828841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus genes controlling reactivation from latency in rabbit eye model.
    Batra SK; Brown SM
    Indian J Med Res; 1990 Jul; 91():252-7. PubMed ID: 2172160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.